Pharma manufacturing news in brief
April 3, 2012Manufacturing and Production Gerresheimer and Foster Wheeler, Pharmax, Sigma-Aldrich
Pharmax starts building Dubai plant, Brazil tightens gelatin controls, plus updates from Sigma-Aldrich, Gerresheimer and Foster Wheeler.
Michael Cola resigns from Shire
April 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Cola, Shire
Michael Cola has resigned as the president of Shire Specialty Pharmaceuticals after seven years at the firm. “On behalf of …
NICE rejects Halaven for breast cancer
April 3, 2012Sales and Marketing Eisai, Halaven, NICE, breast cancer
NICE has rejected Eisai’s novel breast cancer drug Halaven, due to concerns over its safety and costs. In its final …
Moving Towards a Risk-Based approach to Clinical Trial Management
April 3, 2012Research and Development
Clinical trials need to be managed to rigorous standards in order to secure the quality and integrity of every aspect …
Universal WorldEvents Marks Anniversary with Increase in Events
April 2, 2012Sales and Marketing
Universal WorldEvents has marked its first anniversary by revealing a significant increase in the number of events organised by the …
Novartis to construct pharma plant in Turkey
April 2, 2012Manufacturing and Production Novartis, Turkey, manufacturing
Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …
AstraZeneca wins fresh US victory with Seroquel XR
April 2, 2012Sales and Marketing AZ, AstraZeneca, FDA, Seroquel XR
AstraZeneca is celebrating a US court verdict in its ongoing battle for intellectual property over the extended release version of …
Piramal opens ADC plant in Scotland
April 2, 2012Manufacturing and Production ADC, Abbott, Piramel
India’s Piramal Healthcare has officially opened a new production unit to make antibody-drug conjugates at its facility in Grangemouth, Scotland. …
Roche to submit Herceptin successor to regulators
April 2, 2012Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda
Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …
Roche raises Illumina bid to $6.7 billion
April 2, 2012Sales and Marketing
Roche has increased its takeover bid for Illumina, with the offer now valuing the company at $6.7 billion.The firm makes …
Teva sells Canadian plant to CMO
March 30, 2012Manufacturing and Production CMO, Halo Pharmaceutical, Teva, manufacturing
Teva has said it plans to sell a manufacturing facility in Quebec, Canada, to US contract manufacturing organisation Halo Pharmaceutical. …
Amylin dismisses BMS acquisition deal
March 30, 2012Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly
Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …
Merck appoints new chief ethics and compliance officer
March 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck
Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …
NICE recommends Xgeva for bone metastasis
March 29, 2012Sales and Marketing Amgen, NICE, Xgeva, Zytiga, denosumab, prostate cancer
NICE has issued draft guidance recommending Amgen’s Xgeva (denosumab) for certain groups of cancer patients whose disease has spread to …
Approval for Affymax and Takeda’s anaemia treatment
March 29, 2012Sales and Marketing Affymax, Amgen, ESA, Epogen, Takeda, omontys
The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …
Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud
March 29, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines
Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors. Mahmoud, a global infectious …
Prostate cancer drug extends life after chemotherapy
March 29, 2012Research and Development, Sales and Marketing Astellas, Medivation, Zytiga, prostate cancer
Prostate cancer treatment MDV3100 has been shown to extend life by nearly five months in men with advanced disease who …
Janssen to remove its Psoriasis 360 Facebook page
March 28, 2012Medical Communications Facebook, Janssen, PM Soc, Psoriasis 360
Janssen has decided to take down its award-winning Psoriasis 360 page on Facebook, citing an increasing amount of troublesome comments. …
Omnicom Group chooses CAHG as its lead healthcare agency
March 28, 2012Medical Communications CAHG. TBWA, Omnicom, WorldHealth
The Omnicom Group has chosen its healthcare comms agency CAHG to form a strategic alliance with TBWA\WorldHealth as the company’s …
GSK settles cancer patent dispute
March 28, 2012Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents
GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab. The US patents, which relate to recombinant antibody …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
